<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fisch D</submitter><funding>Cancer Research UK</funding><funding>Francis Crick Institute</funding><funding>Medical Research Council</funding><funding>The Francis Crick Institute</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Ministry of Education, Culture, Sports, Science and Technology</funding><funding>Wellcome Trust</funding><funding>Boehringer Ingelheim Fonds</funding><pagination>108008</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7435695</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>32(6)</volume><pubmed_abstract>Interferon-inducible guanylate-binding proteins (GBPs) promote cell-intrinsic defense through host cell death. GBPs target pathogens and pathogen-containing vacuoles and promote membrane disruption for release of microbial molecules that activate inflammasomes. GBP1 mediates pyroptosis or atypical apoptosis of Salmonella Typhimurium (STm)- or Toxoplasma gondii (Tg)- infected human macrophages, respectively. The pathogen-proximal detection-mechanisms of GBP1 remain poorly understood, as humans lack functional immunity-related GTPases (IRGs) that assist murine Gbps. Here, we establish that GBP1 promotes the lysis of Tg-containing vacuoles and parasite plasma membranes, releasing Tg-DNA. In contrast, we show GBP1 targets cytosolic STm and recruits caspase-4 to the bacterial surface for its ac</pubmed_abstract><journal>Cell reports</journal><pubmed_title>Human GBP1 Differentially Targets Salmonella and Toxoplasma to License Recognition of Microbial Ligands and Caspase-Mediated Death.</pubmed_title><pmcid>PMC7435695</pmcid><funding_grant_id>MR/P028225/1</funding_grant_id><funding_grant_id>MC_UP_1202/12</funding_grant_id><funding_grant_id>FC001076</funding_grant_id><funding_grant_id>FC001999</funding_grant_id><funding_grant_id>217202/Z/19/Z</funding_grant_id><funding_grant_id>JP18fk0108046</funding_grant_id><funding_grant_id>MR/P022138/1</funding_grant_id><funding_grant_id>108246/Z/15/Z</funding_grant_id><funding_grant_id>10011</funding_grant_id><funding_grant_id>10076</funding_grant_id><funding_grant_id>17K15677</funding_grant_id><funding_grant_id>091664/B/10/Z</funding_grant_id><funding_grant_id>JP18fk0108047</funding_grant_id><funding_grant_id>10004</funding_grant_id><pubmed_authors>Shenoy AR</pubmed_authors><pubmed_authors>Encheva V</pubmed_authors><pubmed_authors>Yamamoto M</pubmed_authors><pubmed_authors>Frickel EM</pubmed_authors><pubmed_authors>Snijders AP</pubmed_authors><pubmed_authors>Collinson LM</pubmed_authors><pubmed_authors>Clough B</pubmed_authors><pubmed_authors>Bando H</pubmed_authors><pubmed_authors>Fisch D</pubmed_authors><pubmed_authors>Domart MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human GBP1 Differentially Targets Salmonella and Toxoplasma to License Recognition of Microbial Ligands and Caspase-Mediated Death.</name><description>Interferon-inducible guanylate-binding proteins (GBPs) promote cell-intrinsic defense through host cell death. GBPs target pathogens and pathogen-containing vacuoles and promote membrane disruption for release of microbial molecules that activate inflammasomes. GBP1 mediates pyroptosis or atypical apoptosis of Salmonella Typhimurium (STm)- or Toxoplasma gondii (Tg)- infected human macrophages, respectively. The pathogen-proximal detection-mechanisms of GBP1 remain poorly understood, as humans lack functional immunity-related GTPases (IRGs) that assist murine Gbps. Here, we establish that GBP1 promotes the lysis of Tg-containing vacuoles and parasite plasma membranes, releasing Tg-DNA. In contrast, we show GBP1 targets cytosolic STm and recruits caspase-4 to the bacterial surface for its ac</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2026-05-02T21:02:48.8Z</modification><creation>2020-08-24T07:07:27Z</creation></dates><accession>S-EPMC7435695</accession><cross_references><pubmed>32783936</pubmed><doi>10.1016/j.celrep.2020.108008</doi></cross_references></HashMap>